US Firms Tried to Create Artificial Scarcity of Stents Post Price Cap, Shows Industry Data

According to the figures submitted by different manufacturers to the National Pharmaceutical Pricing Authority (NPPA), the opening stock of stents these companies held in January 2018 was 96 per cent more than January 2017.
Market Update
SENSEX 31,622.48 -187.07(%)
NIFTY 9,898.00 -54.2(%)

Top News